Click for best price
Hereditary Cancer Testing Market Size, Share 2022
Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient?s family history is analyzed for any inherited mutation from ancestry. In DNA sequencing, entire DNA or genome of an individual is analyzed. It is useful for testing many genetic mutations at a time.
This report contains market size and forecasts of Hereditary Cancer Testing in Global, including the following market information:
Global Hereditary Cancer Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hereditary Cancer Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
RNA Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hereditary Cancer Testing include Ambry Genetics (Konica Minota), Asper Biogene, Natera, Caris Life Sciences, BioReference Laboratories (GeneDx), LabSolutions, Progenity?Inc, ARUP Laboratories and Myriad, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hereditary Cancer Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hereditary Cancer Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hereditary Cancer Testing Market Segment Percentages, by Type, 2021 (%)
RNA Testing
DNA Testing
Global Hereditary Cancer Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hereditary Cancer Testing Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Global Hereditary Cancer Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hereditary Cancer Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hereditary Cancer Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hereditary Cancer Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity?Inc
ARUP Laboratories
Myriad
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Strand Life Sciences
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics
| Report Attributes |
Report Details |
| Report Title |
Hereditary Cancer Testing Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
107 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hereditary Cancer Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hereditary Cancer Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hereditary Cancer Testing Overall Market Size
2.1 Global Hereditary Cancer Testing Market Size: 2021 VS 2028
2.2 Global Hereditary Cancer Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hereditary Cancer Testing Players in Global Market
3.2 Top Global Hereditary Cancer Testing Companies Ranked by Revenue
3.3 Global Hereditary Cancer Testing Revenue by Companies
3.4 Top 3 and Top 5 Hereditary Cancer Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hereditary Cancer Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hereditary Cancer Testing Players in Global Market
3.6.1 List of Global Tier 1 Hereditary Cancer Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Hereditary Cancer Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hereditary Cancer Testing Market Size Markets, 2021 & 2028
4.1.2 RNA Testing
4.1.3 DNA Testing
4.2 By Type - Global Hereditary Cancer Testing Revenue & Forecasts
4.2.1 By Type - Global Hereditary Cancer Testing Revenue, 2017-2022
4.2.2 By Type - Global Hereditary Cancer Testing Revenue, 2023-2028
4.2.3 By Type - Global Hereditary Cancer Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hereditary Cancer Testing Market Size, 2021 & 2028
5.1.2 Breast Cancer
5.1.3 Gastrointestinal Cancer
5.1.4 Prostate Cancer
5.1.5 Respiratory/Lung Cancer
5.1.6 Other Cancers
5.2 By Application - Global Hereditary Cancer Testing Revenue & Forecasts
5.2.1 By Application - Global Hereditary Cancer Testing Revenue, 2017-2022
5.2.2 By Application - Global Hereditary Cancer Testing Revenue, 2023-2028
5.2.3 By Application - Global Hereditary Cancer Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hereditary Cancer Testing Market Size, 2021 & 2028
6.2 By Region - Global Hereditary Cancer Testing Revenue & Forecasts
6.2.1 By Region - Global Hereditary Cancer Testing Revenue, 2017-2022
6.2.2 By Region - Global Hereditary Cancer Testing Revenue, 2023-2028
6.2.3 By Region - Global Hereditary Cancer Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hereditary Cancer Testing Revenue, 2017-2028
6.3.2 US Hereditary Cancer Testing Market Size, 2017-2028
6.3.3 Canada Hereditary Cancer Testing Market Size, 2017-2028
6.3.4 Mexico Hereditary Cancer Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hereditary Cancer Testing Revenue, 2017-2028
6.4.2 Germany Hereditary Cancer Testing Market Size, 2017-2028
6.4.3 France Hereditary Cancer Testing Market Size, 2017-2028
6.4.4 U.K. Hereditary Cancer Testing Market Size, 2017-2028
6.4.5 Italy Hereditary Cancer Testing Market Size, 2017-2028
6.4.6 Russia Hereditary Cancer Testing Market Size, 2017-2028
6.4.7 Nordic Countries Hereditary Cancer Testing Market Size, 2017-2028
6.4.8 Benelux Hereditary Cancer Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hereditary Cancer Testing Revenue, 2017-2028
6.5.2 China Hereditary Cancer Testing Market Size, 2017-2028
6.5.3 Japan Hereditary Cancer Testing Market Size, 2017-2028
6.5.4 South Korea Hereditary Cancer Testing Market Size, 2017-2028
6.5.5 Southeast Asia Hereditary Cancer Testing Market Size, 2017-2028
6.5.6 India Hereditary Cancer Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hereditary Cancer Testing Revenue, 2017-2028
6.6.2 Brazil Hereditary Cancer Testing Market Size, 2017-2028
6.6.3 Argentina Hereditary Cancer Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hereditary Cancer Testing Revenue, 2017-2028
6.7.2 Turkey Hereditary Cancer Testing Market Size, 2017-2028
6.7.3 Israel Hereditary Cancer Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Hereditary Cancer Testing Market Size, 2017-2028
6.7.5 UAE Hereditary Cancer Testing Market Size, 2017-2028
7 Players Profiles
7.1 Ambry Genetics (Konica Minota)
7.1.1 Ambry Genetics (Konica Minota) Corporate Summary
7.1.2 Ambry Genetics (Konica Minota) Business Overview
7.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Major Product Offerings
7.1.4 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.1.5 Ambry Genetics (Konica Minota) Key News
7.2 Asper Biogene
7.2.1 Asper Biogene Corporate Summary
7.2.2 Asper Biogene Business Overview
7.2.3 Asper Biogene Hereditary Cancer Testing Major Product Offerings
7.2.4 Asper Biogene Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.2.5 Asper Biogene Key News
7.3 Natera
7.3.1 Natera Corporate Summary
7.3.2 Natera Business Overview
7.3.3 Natera Hereditary Cancer Testing Major Product Offerings
7.3.4 Natera Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.3.5 Natera Key News
7.4 Caris Life Sciences
7.4.1 Caris Life Sciences Corporate Summary
7.4.2 Caris Life Sciences Business Overview
7.4.3 Caris Life Sciences Hereditary Cancer Testing Major Product Offerings
7.4.4 Caris Life Sciences Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.4.5 Caris Life Sciences Key News
7.5 BioReference Laboratories (GeneDx)
7.5.1 BioReference Laboratories (GeneDx) Corporate Summary
7.5.2 BioReference Laboratories (GeneDx) Business Overview
7.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Major Product Offerings
7.5.4 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.5.5 BioReference Laboratories (GeneDx) Key News
7.6 LabSolutions
7.6.1 LabSolutions Corporate Summary
7.6.2 LabSolutions Business Overview
7.6.3 LabSolutions Hereditary Cancer Testing Major Product Offerings
7.6.4 LabSolutions Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.6.5 LabSolutions Key News
7.7 Progenity?Inc
7.7.1 Progenity?Inc Corporate Summary
7.7.2 Progenity?Inc Business Overview
7.7.3 Progenity?Inc Hereditary Cancer Testing Major Product Offerings
7.7.4 Progenity?Inc Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.7.5 Progenity?Inc Key News
7.8 ARUP Laboratories
7.8.1 ARUP Laboratories Corporate Summary
7.8.2 ARUP Laboratories Business Overview
7.8.3 ARUP Laboratories Hereditary Cancer Testing Major Product Offerings
7.8.4 ARUP Laboratories Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.8.5 ARUP Laboratories Key News
7.9 Myriad
7.9.1 Myriad Corporate Summary
7.9.2 Myriad Business Overview
7.9.3 Myriad Hereditary Cancer Testing Major Product Offerings
7.9.4 Myriad Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.9.5 Myriad Key News
7.10 NeoGenomics
7.10.1 NeoGenomics Corporate Summary
7.10.2 NeoGenomics Business Overview
7.10.3 NeoGenomics Hereditary Cancer Testing Major Product Offerings
7.10.4 NeoGenomics Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.10.5 NeoGenomics Key News
7.11 Blueprint Genetics
7.11.1 Blueprint Genetics Corporate Summary
7.11.2 Blueprint Genetics Business Overview
7.11.3 Blueprint Genetics Hereditary Cancer Testing Major Product Offerings
7.11.4 Blueprint Genetics Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.11.5 Blueprint Genetics Key News
7.12 CellMax Life
7.12.1 CellMax Life Corporate Summary
7.12.2 CellMax Life Business Overview
7.12.3 CellMax Life Hereditary Cancer Testing Major Product Offerings
7.12.4 CellMax Life Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.12.5 CellMax Life Key News
7.13 Fulgent Genetics
7.13.1 Fulgent Genetics Corporate Summary
7.13.2 Fulgent Genetics Business Overview
7.13.3 Fulgent Genetics Hereditary Cancer Testing Major Product Offerings
7.13.4 Fulgent Genetics Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.13.5 Fulgent Genetics Key News
7.14 Strand Life Sciences
7.14.1 Strand Life Sciences Corporate Summary
7.14.2 Strand Life Sciences Business Overview
7.14.3 Strand Life Sciences Hereditary Cancer Testing Major Product Offerings
7.14.4 Strand Life Sciences Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.14.5 Strand Life Sciences Key News
7.15 Myogenes
7.15.1 Myogenes Corporate Summary
7.15.2 Myogenes Business Overview
7.15.3 Myogenes Hereditary Cancer Testing Major Product Offerings
7.15.4 Myogenes Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.15.5 Myogenes Key News
7.16 LabCorp
7.16.1 LabCorp Corporate Summary
7.16.2 LabCorp Business Overview
7.16.3 LabCorp Hereditary Cancer Testing Major Product Offerings
7.16.4 LabCorp Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.16.5 LabCorp Key News
7.17 Quest Diagnostics
7.17.1 Quest Diagnostics Corporate Summary
7.17.2 Quest Diagnostics Business Overview
7.17.3 Quest Diagnostics Hereditary Cancer Testing Major Product Offerings
7.17.4 Quest Diagnostics Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.17.5 Quest Diagnostics Key News
7.18 Pathway Genomics
7.18.1 Pathway Genomics Corporate Summary
7.18.2 Pathway Genomics Business Overview
7.18.3 Pathway Genomics Hereditary Cancer Testing Major Product Offerings
7.18.4 Pathway Genomics Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.18.5 Pathway Genomics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hereditary Cancer Testing Market Opportunities & Trends in Global Market
Table 2. Hereditary Cancer Testing Market Drivers in Global Market
Table 3. Hereditary Cancer Testing Market Restraints in Global Market
Table 4. Key Players of Hereditary Cancer Testing in Global Market
Table 5. Top Hereditary Cancer Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hereditary Cancer Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hereditary Cancer Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hereditary Cancer Testing Product Type
Table 9. List of Global Tier 1 Hereditary Cancer Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hereditary Cancer Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hereditary Cancer Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hereditary Cancer Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hereditary Cancer Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hereditary Cancer Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hereditary Cancer Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hereditary Cancer Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hereditary Cancer Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hereditary Cancer Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hereditary Cancer Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hereditary Cancer Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hereditary Cancer Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hereditary Cancer Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hereditary Cancer Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hereditary Cancer Testing Revenue, (US$, Mn), 2023-2028
Table 30. Ambry Genetics (Konica Minota) Corporate Summary
Table 31. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product Offerings
Table 32. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 33. Asper Biogene Corporate Summary
Table 34. Asper Biogene Hereditary Cancer Testing Product Offerings
Table 35. Asper Biogene Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 36. Natera Corporate Summary
Table 37. Natera Hereditary Cancer Testing Product Offerings
Table 38. Natera Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 39. Caris Life Sciences Corporate Summary
Table 40. Caris Life Sciences Hereditary Cancer Testing Product Offerings
Table 41. Caris Life Sciences Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 42. BioReference Laboratories (GeneDx) Corporate Summary
Table 43. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product Offerings
Table 44. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 45. LabSolutions Corporate Summary
Table 46. LabSolutions Hereditary Cancer Testing Product Offerings
Table 47. LabSolutions Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 48. Progenity?Inc Corporate Summary
Table 49. Progenity?Inc Hereditary Cancer Testing Product Offerings
Table 50. Progenity?Inc Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 51. ARUP Laboratories Corporate Summary
Table 52. ARUP Laboratories Hereditary Cancer Testing Product Offerings
Table 53. ARUP Laboratories Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 54. Myriad Corporate Summary
Table 55. Myriad Hereditary Cancer Testing Product Offerings
Table 56. Myriad Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 57. NeoGenomics Corporate Summary
Table 58. NeoGenomics Hereditary Cancer Testing Product Offerings
Table 59. NeoGenomics Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 60. Blueprint Genetics Corporate Summary
Table 61. Blueprint Genetics Hereditary Cancer Testing Product Offerings
Table 62. Blueprint Genetics Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 63. CellMax Life Corporate Summary
Table 64. CellMax Life Hereditary Cancer Testing Product Offerings
Table 65. CellMax Life Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 66. Fulgent Genetics Corporate Summary
Table 67. Fulgent Genetics Hereditary Cancer Testing Product Offerings
Table 68. Fulgent Genetics Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 69. Strand Life Sciences Corporate Summary
Table 70. Strand Life Sciences Hereditary Cancer Testing Product Offerings
Table 71. Strand Life Sciences Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 72. Myogenes Corporate Summary
Table 73. Myogenes Hereditary Cancer Testing Product Offerings
Table 74. Myogenes Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 75. LabCorp Corporate Summary
Table 76. LabCorp Hereditary Cancer Testing Product Offerings
Table 77. LabCorp Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 78. Quest Diagnostics Corporate Summary
Table 79. Quest Diagnostics Hereditary Cancer Testing Product Offerings
Table 80. Quest Diagnostics Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 81. Pathway Genomics Corporate Summary
Table 82. Pathway Genomics Hereditary Cancer Testing Product Offerings
Table 83. Pathway Genomics Hereditary Cancer Testing Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hereditary Cancer Testing Segment by Type in 2021
Figure 2. Hereditary Cancer Testing Segment by Application in 2021
Figure 3. Global Hereditary Cancer Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hereditary Cancer Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hereditary Cancer Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2021
Figure 8. By Type - Global Hereditary Cancer Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hereditary Cancer Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hereditary Cancer Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hereditary Cancer Testing Revenue Market Share, 2017-2028
Figure 12. US Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hereditary Cancer Testing Revenue Market Share, 2017-2028
Figure 16. Germany Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hereditary Cancer Testing Revenue Market Share, 2017-2028
Figure 24. China Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hereditary Cancer Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hereditary Cancer Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hereditary Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Asper Biogene Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Natera Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Caris Life Sciences Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. LabSolutions Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Progenity?Inc Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. ARUP Laboratories Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Myriad Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. NeoGenomics Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Blueprint Genetics Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. CellMax Life Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Fulgent Genetics Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Strand Life Sciences Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Myogenes Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. LabCorp Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Quest Diagnostics Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Pathway Genomics Hereditary Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
